Cellular and molecular features related to exceptional therapy response and extreme long‐term survival in glioblastoma

Glioblastoma Multiforme (GBM) remains the most common malignant primary brain tumor with a dismal prognosis that rarely exceeds beyond 2 years despite extensive therapy, which consists of maximal safe surgical resection, radiotherapy, and/or chemotherapy. Recently, it has become clear that GBM is no...

Descripción completa

Detalles Bibliográficos
Autores principales: Decraene, B., Vanmechelen, M., Clement, P., Daisne, J. F., Vanden Bempt, I., Sciot, R., Garg, A. D., Agostinis, P., De Smet, F., De Vleeschouwer, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
REVIEWS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242322/
https://www.ncbi.nlm.nih.gov/pubmed/36776000
http://dx.doi.org/10.1002/cam4.5681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242322/
https://www.ncbi.nlm.nih.gov/pubmed/36776000
http://dx.doi.org/10.1002/cam4.5681

Ejemplares similares